Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399979![]() (US10323042, Example 58) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399978![]() (US10323042, Example 57) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.86 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399927![]() ((6S)-3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropyl...) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399928![]() (3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6,6-difl...) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 5.29 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399973![]() (US10323042, Example 53A | US10323042, Example 53B) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 5.35 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399978![]() (US10323042, Example 57) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 5.66 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399973![]() (US10323042, Example 53A | US10323042, Example 53B) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 6.45 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399927![]() ((6S)-3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropyl...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 6.51 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399979![]() (US10323042, Example 58) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 8.52 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399973![]() (US10323042, Example 53A | US10323042, Example 53B) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 10.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399937![]() (US10323042, Example 17) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399971![]() (US10323042, Example 51) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399968![]() (US10323042, Example 48) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 12.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399969![]() (US10323042, Example 49) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 13.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399926![]() ((6S)-3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6-f...) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 14.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399967![]() (US10323042, Example 47) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 15.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform 1 (Homo sapiens (Human)) | BDBM399979![]() (US10323042, Example 58) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 16.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399960![]() (US10323042, Example 40) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 19.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399964![]() (US10323042, Example 44) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 20.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399937![]() (US10323042, Example 17) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 21.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399938![]() (US10323042, Example 18) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 23.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399975![]() (US10323042, Example 54) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 25.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399958![]() (US10323042, Example 38) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 26.2 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399971![]() (US10323042, Example 51) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 26.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399923![]() (Azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)-6,7-...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 27.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399928![]() (3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6,6-difl...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 28.2 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform 1 (Homo sapiens (Human)) | BDBM399978![]() (US10323042, Example 57) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 28.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399973![]() (US10323042, Example 53A | US10323042, Example 53B) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 29.2 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform 1 (Homo sapiens (Human)) | BDBM399927![]() ((6S)-3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropyl...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 31.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399923![]() (Azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)-6,7-...) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 31.9 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399939![]() (US10323042, Example 19) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 32.9 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399925![]() (3-(4-Cyano-5-fluoro-2-methylphenyl)-N-cyclopropyl-...) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 34.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399936![]() (US10323042, Example 16) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 36.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399934![]() (US10323042, Example 14) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 37.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399963![]() (US10323042, Example 43) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399970![]() (US10323042, Example 50) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 40.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399938![]() (US10323042, Example 18) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 40.9 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399959![]() (US10323042, Example 39) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399926![]() ((6S)-3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6-f...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 44.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform 1 (Homo sapiens (Human)) | BDBM399967![]() (US10323042, Example 47) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 45.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399936![]() (US10323042, Example 16) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 46 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform 1 (Homo sapiens (Human)) | BDBM399952![]() (US10323042, Example 32) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 48.2 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399933![]() (US10323042, Example 13) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 50.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399960![]() (US10323042, Example 40) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 53.2 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399964![]() (US10323042, Example 44) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 55.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399956![]() (US10323042, Example 36) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 56 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399933![]() (US10323042, Example 13) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 57 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human)) | BDBM399935![]() (US10323042, Example 15) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 57.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform 1 (Homo sapiens (Human)) | BDBM399968![]() (US10323042, Example 48) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 63.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399965![]() (US10323042, Example 45) | PDB GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 64 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) Article DOI: null BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 246 total ) | Next | Last >> |